文献速递儿童神经与发育行为儿童内分泌与遗传代谢

结合详细病史重新解读染色体微阵列结果

Reinterpretation of Chromosomal Microarrays with Detailed Medical History.
PubMed 文献 · J Pediatr · 2020-05-13

本研究回顾性重新解读2011至2013年998例儿科染色体微阵列结果,结合完整电子病历(cEMR)重新分类变异。482例存在变异,其中34%(164/482)的解读发生改变,主要是不确定变异(VUS)降级为良性/可能良性;总体16.4%(164/998)的患者解读改变。获取cEMR可减少VUS解读,改善微阵列结果解读。

要点

  • 结合完整电子病历重新解读,34%的变异解读发生改变
  • 156例VUS降级为良性/可能良性,7例VUS升级为致病/可能致病
  • 无致病/可能致病变异的解读发生改变

核心结论

  • 结合患者完整电子病历可改善染色体微阵列解读,减少不确定变异(VUS)的数量。

研究设计与样本

  • 回顾性重新解读2011至2013年998例儿科患者染色体微阵列结果,结合完整电子病历(cEMR)重新分析既往报告的遗传变异,采用三级分类系统:致病/可能致病(P/LP)、不确定意义变异(VUS)、良性/可能良性(B/LB)。

主要发现

  • 998例中482例(48%)检出至少一个变异,516例报告阴性。
  • 482例有变异患者中,原始解读为P/LP占19.3%(93/482)、VUS占44.8%(216/482)、B/LB占35.9%(173/482)。
  • 结合cEMR后,34%(164/482)的患者结果解读发生改变:1例B/LB变为VUS,7例VUS升级为P/LP,156例VUS降级为B/LB;无P/LP变异解读改变。
  • 总体16.4%(164/998)的患者染色体微阵列解读发生改变。

临床怎么用

  • 儿科解读染色体微阵列结果时,应结合患者完整电子病历中的详细病史,以降低VUS比例、提高解读准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the utility of a detailed medical history in the interpretation of chromosomal microarray results for pediatric patients with a constitutional disease. STUDY DESIGN: A retrospective review and reinterpretation of test results from chromosomal microarrays performed from 2011 to 2013. Previously reported genetic variants were reanalyzed after review of the patient's complete electronic medical record (cEMR). A 3-tier system was used for reclassification of variants: pathogenic or likely pathogenic (P/LP); variant of uncertain significance (VUS); or benign or likely benign (B/LB). RESULTS: Over an 18-month period, 998 patients with chromosomal microarray results were identified. The most common reasons for chromosomal microarray testing were developmental delay (n = 336), autism spectrum disorder (n = 241), and seizures (n = 143). Chromosomal microarray testing identified 1 or more variants in 48% (482 of 998) of patients; 516 patients had a negative report. For the 482 patients with variants, the original interpretations were composed of 19.3% P/LP (93 of 482), 44.8% VUS (216 of 482), and 35.9% B/LB (173 of 482) variants. After review of the cEMR, 34% of patient results (164 of 482) were changed in interpretation. One case changed from B/LB to VUS, 7 VUS were upgraded to P/LP, and 156 VUS were downgraded to B/LB. No P/LP variants had a change in interpretation. CONCLUSIONS: Overall, 16.4% (164 of 998) of patients with chromosomal microarray testing had a change in interpretation. Access to the patient's cEMR improves the interpretation of chromosomal microarrays by decreasing the number of uncertain (VUS) interpretations.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Farooqi MS, Figueroa S, Gotway G, et al. Reinterpretation of Chromosomal Microarrays with Detailed Medical History. J Pediatr. 2020. PMID: 32417076. doi:10.1016/j.jpeds.2020.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。